AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9106016 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 5-day course (10 mg/kg on day 1 and 5 mg/kg on days 2‐5)
Number of subjects: 371
Study 8197429 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood cardioplegia
Number of subjects: 100
Study 8197429 — intervention group
Group type: COMPARATOR
Intervention: Crystalloid cardioplegia
Number of subjects: 100
Study 8197429 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 100
Study 3492153 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimodipine (0.09 mg/kg X h)
Number of subjects: 52
Study 3492153 — intervention group
Group type: COMPARATOR
Intervention: Control (0.9% saline solution)
Number of subjects: 52
Study 30413328 — intervention group
Group type: EXPERIMENTAL
Intervention: Public support for policy strategies targeting schools, marketing, and the built environment.
Number of subjects: 2066
Study 30413328 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceptions of factors contributing to childhood obesity.
Number of subjects: 2066
Study 30413328 — intervention group
Group type: EXPERIMENTAL
Intervention: Attribution of responsibility for childhood obesity.
Number of subjects: 2066
Study 28560802 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg prednisolone
Number of subjects: 400
Study 28560802 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study 27103409 — intervention group
Group type: COMPARATOR
Intervention: Enhanced care (screening recommendation and FOBT kit mailed annually)
Number of subjects: 206
Study 27103409 — intervention group
Group type: COMPARATOR
Intervention: Education (health literacy appropriate pamphlet and simplified FOBT instructions)
Number of subjects: 206
Study 27103409 — intervention group
Group type: COMPARATOR
Intervention: Nurse support (same as education but with nurse follow-up)
Number of subjects: 206
Study 27103409 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 206
Study 24702700 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin degludec (IDeg)
Number of subjects: 455
Study 24702700 — intervention group
Group type: COMPARATOR
Intervention: Insulin detemir (IDet)
Number of subjects: 455
Study 21441205 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecologically based weight gain prevention interventions
Number of subjects: 0
Study 21441205 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention adoption by sites
Number of subjects: 0
Study 21441205 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy eating interventions
Number of subjects: 0
Study 21441205 — intervention group
Group type: EXPERIMENTAL
Intervention: Institutional level maintenance of interventions
Number of subjects: 0
Study 20981001 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoxifen, single oral doses ranging from 0.5 to 4.0 mg
Number of subjects: 0
Study 18843429 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical spine mobilization
Number of subjects: 15
Study 18843429 — intervention group
Group type: COMPARATOR
Intervention: Control (socializing visits)
Number of subjects: 15
Study 15701465 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 weeks of exercise training (5 days/week, submaximal bicycle ergometer training, 30 min/day; calisthenics 9 min/day)
Number of subjects: 18
Study 15701465 — intervention group
Group type: COMPARATOR
Intervention: 8 weeks of rest
Number of subjects: 18
Study 11850257 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg of amprenavir with 100 mg of ritonavir twice daily
Number of subjects: 0
Study 11850257 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily regimens
Number of subjects: 0
Study 10188720 — intervention group
Group type: EXPERIMENTAL
Intervention: TIL from tumor biopsies
Number of subjects: 9
Study 10188720 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-2-stimulated TIL cell lines
Number of subjects: 9
Study 7757892 — intervention group
Group type: EXPERIMENTAL
Intervention: Newsletter recipients (experimental group)
Number of subjects: 453
Study 7757892 — intervention group
Group type: COMPARATOR
Intervention: Nonrecipients (control group)
Number of subjects: 453
Study 2334625 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium Nitroprusside (SNP)
Number of subjects: 30
Study 2334625 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 30
Study 2334625 — intervention group
Group type: EXPERIMENTAL
Intervention: Urapidil
Number of subjects: 30
Study 84259 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate-day prednisone (35 mg/m2/48 h)
Number of subjects: 23
Study 84259 — intervention group
Group type: COMPARATOR
Intervention: Intermittent prednisone (40 mg/m2 on three consecutive days out of seven)
Number of subjects: 23
Study 31107694 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic and Resistance Training (ART) for 12 weeks
Number of subjects: 141
Study 31107694 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine Training (TCMT) for 12 weeks
Number of subjects: 141
Study 31107694 — intervention group
Group type: COMPARATOR
Intervention: Control (CON) group
Number of subjects: 141
Study 28285001 — intervention group
Group type: EXPERIMENTAL
Intervention: Footwear for self-management
Number of subjects: 91
Study 25827607 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced rider training course 'Risk' (n=137)
Number of subjects: 222
Study 25827607 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=85)
Number of subjects: 222
Study 23519654 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-week self-management intervention (n=68)
Number of subjects: 147
Study 23519654 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=78)
Number of subjects: 147
Study 20869706 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonists combined with GnRH antagonists
Number of subjects: 0
Study 20869706 — intervention group
Group type: COMPARATOR
Intervention: GnRH agonists alone
Number of subjects: 0
Study 19560257 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine (GEM) 2000 mg/100 ml of saline
Number of subjects: 328
Study 19560257 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO) 100 ml of saline
Number of subjects: 328
Study 17126613 — intervention group
Group type: EXPERIMENTAL
Intervention: Health insurance scheme benefits uptake strategies
Number of subjects: 0
Study 17126613 — intervention group
Group type: EXPERIMENTAL
Intervention: Socioeconomic status index
Number of subjects: 0
Study 17126613 — intervention group
Group type: EXPERIMENTAL
Intervention: Rank score interpolation
Number of subjects: 0
Study 15001970 — intervention group
Group type: EXPERIMENTAL
Intervention: St John's wort (300 mg tablet, 3 times daily for 14 days)
Number of subjects: 12
Study 11771044 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% aqueous sodium bicarbonate
Number of subjects: 69
Study 11771044 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% aqueous acetic acid
Number of subjects: 69
Study 9225180 — intervention group
Group type: EXPERIMENTAL
Intervention: OKN testing (slow and fast clockwise and counterclockwise)
Number of subjects: 70
Study 9225180 — intervention group
Group type: EXPERIMENTAL
Intervention: OKN testing (slow movements)
Number of subjects: 70
Study 9225180 — intervention group
Group type: EXPERIMENTAL
Intervention: OKN testing (fast movements)
Number of subjects: 70
Study 9225180 — intervention group
Group type: EXPERIMENTAL
Intervention: OKN testing (saccades)
Number of subjects: 70
Study 8281588 — intervention group
Group type: EXPERIMENTAL
Intervention: 25G Whitacre needle
Number of subjects: 304
Study 8281588 — intervention group
Group type: COMPARATOR
Intervention: 24G Sprotte needle
Number of subjects: 304
Study 3544754 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg nisoldipine
Number of subjects: 10
Study 3544754 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg nisoldipine
Number of subjects: 10
Study 3544754 — intervention group
Group type: COMPARATOR
Intervention: 20 mg nifedipine
Number of subjects: 10
Study 2702166 — intervention group
Group type: EXPERIMENTAL
Intervention: Gracey curette 5/6
Number of subjects: 140
Study 2702166 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound unit
Number of subjects: 140
Study 2702166 — intervention group
Group type: EXPERIMENTAL
Intervention: Air scalers with five different tips
Number of subjects: 140
Study 2702166 — intervention group
Group type: EXPERIMENTAL
Intervention: Sharp-edged instruments
Number of subjects: 140
Study 2702166 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic calculus removal instruments
Number of subjects: 140
Study 31176375 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow oxygen therapy (HFOT) during high-intensity exercise training
Number of subjects: 156
Study 31176375 — intervention group
Group type: COMPARATOR
Intervention: Standard oxygen delivery via Venturi Mask (V-mask) during high-intensity exercise training
Number of subjects: 156
Study 28651483 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive information about the energy drink (augments running performance)
Number of subjects: 60
Study 28651483 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial-positive information about the energy drink (may or may not improve performance)
Number of subjects: 60
Study 28651483 — intervention group
Group type: COMPARATOR
Intervention: Neutral information (control group) about the energy drink (could not demonstrate improvement)
Number of subjects: 60
Study 26517265 — intervention group
Group type: EXPERIMENTAL
Intervention: Mujer Segura intervention
Number of subjects: 77
Study 23109095 — intervention group
Group type: EXPERIMENTAL
Intervention: ACI and additional HTO (Group A, n = 19)
Number of subjects: 43
Study 23109095 — intervention group
Group type: COMPARATOR
Intervention: ACI only (Group B, n = 24)
Number of subjects: 43
Study 21796026 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting without back support position (SB) intervention
Number of subjects: 3
Study 19364680 — intervention group
Group type: EXPERIMENTAL
Intervention: Video (n = 40)
Number of subjects: 80
Study 19364680 — intervention group
Group type: COMPARATOR
Intervention: Text (n = 40)
Number of subjects: 80
Study 16759446 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate infusion
Number of subjects: 0
Study 16759446 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15527158 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based directly observed treatment (DOT) using guardians and former TB patients
Number of subjects: 587
Study 15527158 — intervention group
Group type: COMPARATOR
Intervention: Health facility-based directly observed treatment (DOT)
Number of subjects: 587
Study 11156732 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 45
Study 11156732 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 45
Study 9065189 — intervention group
Group type: EXPERIMENTAL
Intervention: Episiotomy
Number of subjects: 459
Study 9065189 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 459
Study 9065189 — intervention group
Group type: COMPARATOR
Intervention: Control (no episiotomy)
Number of subjects: 459
Study 9065189 — intervention group
Group type: EXPERIMENTAL
Intervention: Shorter second stage of labor
Number of subjects: 459
Study 9065189 — intervention group
Group type: EXPERIMENTAL
Intervention: Unemployment
Number of subjects: 459
Study 9065189 — intervention group
Group type: EXPERIMENTAL
Intervention: Forceps use and birth weight
Number of subjects: 459
Study 9065189 — intervention group
Group type: EXPERIMENTAL
Intervention: Antepartum pelvic floor strength
Number of subjects: 459
Study 8267425 — intervention group
Group type: EXPERIMENTAL
Intervention: EC + BN 52021 (10 mg/kg)
Number of subjects: 28
Study 8267425 — intervention group
Group type: COMPARATOR
Intervention: EC (40 mL/kg)
Number of subjects: 28
Study 3534041 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress management techniques (six classes including autogenics, personal planning skills, and communication techniques)
Number of subjects: 80
Study 3534041 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 80
Study 30871934 — intervention group
Group type: EXPERIMENTAL
Intervention: Nestorone (NES) 200 mcg/day and estradiol (E2) 10 mcg/day
Number of subjects: 189
Study 30871934 — intervention group
Group type: EXPERIMENTAL
Intervention: Nestorone (NES) 200 mcg/day and estradiol (E2) 20 mcg/day
Number of subjects: 189
Study 30871934 — intervention group
Group type: EXPERIMENTAL
Intervention: Nestorone (NES) 200 mcg/day and estradiol (E2) 40 mcg/day
Number of subjects: 189
Study 27887033 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% diclofenac + 3% menthol
Number of subjects: 0
Study 27887033 — intervention group
Group type: EXPERIMENTAL
Intervention: Menthol gel
Number of subjects: 0
Study 27887033 — intervention group
Group type: COMPARATOR
Intervention: Positive control (0.2% sodium lauryl sulfate)
Number of subjects: 0
Study 27887033 — intervention group
Group type: COMPARATOR
Intervention: Reference treatments (0.9% saline and marketed gel 1% diclofenac, Voltaren)
Number of subjects: 0
Study 25683796 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (cycling for one hour at 50% of maximum oxygen uptake)
Number of subjects: 20
Study 25683796 — intervention group
Group type: COMPARATOR
Intervention: Control (three hours of rest)
Number of subjects: 20
Study 25683796 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (for inactive participants)
Number of subjects: 20
Study 25683796 — intervention group
Group type: EXPERIMENTAL
Intervention: Active participants
Number of subjects: 20
Study 23740384 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 ml LZD suspension
Number of subjects: 28
Study 23740384 — intervention group
Group type: COMPARATOR
Intervention: 600 mg LZD tablet
Number of subjects: 28
Study 21940789 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN‐γ1b
Number of subjects: 1156
Study 18192318 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibrating bladder stimulator
Number of subjects: 97
Study 18192318 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 97
Study 17162142 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-protein diet (0.58 g/kg/d)
Number of subjects: 585
Study 17162142 — intervention group
Group type: COMPARATOR
Intervention: Usual-protein diet (1.3 g/kg/d)
Number of subjects: 585
Study 14572566 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 L sulfate‐free electrolyte lavage solution (SF‐ELS) plus 20 mg p.o. bisacodyl
Number of subjects: 200
Study 14572566 — intervention group
Group type: COMPARATOR
Intervention: 4 L sulfate-free electrolyte lavage solution (SF‐ELS)
Number of subjects: 200
Study 10050112 — intervention group
Group type: EXPERIMENTAL
Intervention: Cast posts and cores
Number of subjects: 60
Study 10050112 — intervention group
Group type: EXPERIMENTAL
Intervention: Prefabricated, comparably sized, parallel-sided posts with composite cores
Number of subjects: 60
Study 10050112 — intervention group
Group type: EXPERIMENTAL
Intervention: Woven fiber post-core system
Number of subjects: 60
Study 10050112 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene woven fiber and composite resin without a prefabricated post
Number of subjects: 60
Study 10050112 — intervention group
Group type: EXPERIMENTAL
Intervention: Smaller diameter prefabricated posts combined with polyethylene woven fiber and composite cores
Number of subjects: 60
Study 10050112 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional cast posts and cores
Number of subjects: 60
Study 8678252 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-rigid cervical collar
Number of subjects: 38
Study 8678252 — intervention group
Group type: COMPARATOR
Intervention: Changing support of the airway
Number of subjects: 38
Study 2202247 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide 30 mg
Number of subjects: 7
Study 2202247 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 6265966 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidemiologic Catchment Area Program (ECA Program)
Number of subjects: 0
Study 30427880 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-minute warning system using machine learning algorithms (random forests and support vector machines)
Number of subjects: 788
Study 30427880 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-second warning system using machine learning algorithms (random forests and support vector machines)
Number of subjects: 788
Study 27558396 — intervention group
Group type: EXPERIMENTAL
Intervention: High trans-fatty acids beverage
Number of subjects: 11
Study 27558396 — intervention group
Group type: COMPARATOR
Intervention: High saturated fatty acids beverage
Number of subjects: 11
Study 25468506 — intervention group
Group type: EXPERIMENTAL
Intervention: REAP-HD programme
Number of subjects: 0
Study 25468506 — intervention group
Group type: COMPARATOR
Intervention: Standard Staff Education (SSE)
Number of subjects: 0
Study 22267336 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation (including folate, zinc, and vitamins A, B, C, and D)
Number of subjects: 58
Study 22267336 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 58
Study 20018483 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplemented formula (Lactobacillus salivarius CECT5713, 2 × 10(6) cfu/g)
Number of subjects: 80
Study 20018483 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no probiotics)
Number of subjects: 80
Study 18806036 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided technique
Number of subjects: 99
Study 18806036 — intervention group
Group type: COMPARATOR
Intervention: Digital technique
Number of subjects: 99
Study 18806036 — intervention group
Group type: COMPARATOR
Intervention: Introducer tool (IT) technique
Number of subjects: 99
Study 15941684 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucan treatment for 12 weeks
Number of subjects: 24
Study 15941684 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment for 12 weeks
Number of subjects: 24
Study 11813228 — intervention group
Group type: EXPERIMENTAL
Intervention: Latent class mixed models applied to longitudinal data on prostate specific antigen (PSA) and incidence of prostate cancer.
Number of subjects: 0
Study 11813228 — intervention group
Group type: EXPERIMENTAL
Intervention: Latent class mixed models for survival endpoint analysis of prostate cancer.
Number of subjects: 0
Study 9690721 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg b.d.
Number of subjects: 16
Study 9690721 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg b.d.
Number of subjects: 16
Study 9690721 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 20 mg o.d.
Number of subjects: 16
Study 9690721 — intervention group
Group type: COMPARATOR
Intervention: Lansoprazole 30 mg o.d.
Number of subjects: 16
Study 7806479 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide-band chirp signals
Number of subjects: 0
Study 7806479 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency-limited chirps
Number of subjects: 0
Study 7806479 — intervention group
Group type: EXPERIMENTAL
Intervention: Chirp stimuli
Number of subjects: 0
Study 2764288 — intervention group
Group type: EXPERIMENTAL
Intervention: Active airway humidification using an airway heater and humidifier set at 37 degrees C (N = 8)
Number of subjects: 20
Study 2764288 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive airway humidification using a heat and moisture exchanger (N = 6)
Number of subjects: 20
Study 2764288 — intervention group
Group type: COMPARATOR
Intervention: No airway humidification and/or heating (control, N = 6)
Number of subjects: 20
Study 789219 — intervention group
Group type: EXPERIMENTAL
Intervention: Frubienzym (throat lozenges with 5 mg lysozyme, 2 mg papaine and 200 I.U. bacitracin)
Number of subjects: 100
Study 789219 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 31074115 — intervention group
Group type: EXPERIMENTAL
Intervention: Incident VTE in SCD patients
Number of subjects: 877
Study 31074115 — intervention group
Group type: EXPERIMENTAL
Intervention: More severe SCD
Number of subjects: 877
Study 31074115 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower extremity DVT as the incident event
Number of subjects: 877
Study 31074115 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumonia/acute chest syndrome
Number of subjects: 877
Study 25997633 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive educational intervention (small-group session and e-learning)
Number of subjects: 1600
Study 25997633 — intervention group
Group type: COMPARATOR
Intervention: Standard approach (control group)
Number of subjects: 1600
Study 23801589 — intervention group
Group type: EXPERIMENTAL
Intervention: CALM treatment
Number of subjects: 1004
Study 21777477 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured, progressive exercise program (12 weeks, resistance exercises with exercise bands, 1 supervised session/week, at least 2 non-supervised sessions/week)
Number of subjects: 80
Study 21777477 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured, progressive exercise program
Number of subjects: 80
Study 21777477 — intervention group
Group type: COMPARATOR
Intervention: Usual care (including psychotherapy, pharmaceutical interventions, and group therapy)
Number of subjects: 80
Study 19623867 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (30-50 mg/kg bolus followed by 500 mg/h continuous infusion)
Number of subjects: 68
Study 19623867 — intervention group
Group type: COMPARATOR
Intervention: Isotonic solution (control group)
Number of subjects: 68
Study 19623867 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate
Number of subjects: 68
Study 17101743 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline 1 mg daily
Number of subjects: 12
Study 17101743 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline 2 mg daily
Number of subjects: 12
Study 17101743 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline 3 mg daily
Number of subjects: 12
Study 17101743 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline 1 mg twice daily
Number of subjects: 12
Study 17101743 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline 2 mg twice daily
Number of subjects: 12
Study 17101743 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 15603006 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-session vocational problem solving intervention (N=62)
Number of subjects: 109
Study 15603006 — intervention group
Group type: COMPARATOR
Intervention: Time and attention control condition (N=47)
Number of subjects: 109